- CEO
- Viroj Chaiterdkiat
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Phra Samut Chedi Thailand
- IPO Date
- Oct 31, 2023
- Business
- Namwiwat Medical Corporation Public Company Limited manufactures, distributes, and services medical cleaning, disinfection, and sterilization equipment, medical supplies, and healthcare waste treatment systems in Thailand and internationally. The company operates through three primary business segments: Manufacture and Sale of Medical Equipment; Sale of Medical Supplies and Consumables; and Healthcare Services and Turnkey Engineering Solutions. Its core product portfolio comprises steam autoclaves, low-temperature hydrogen peroxide gas plasma sterilizers, ethylene oxide gas sterilizers, washer-disinfectors, automated ultrasonic cleaning units, medical drying cabinets, pure steam generators, and on-site infectious medical waste treatment systems; medical consumables and single-use supplies, including sterilization pouches, wrapping fabrics, chemical indicator strips, biological indicators, enzymatic cleaning detergents, surgical instruments, and personal protective equipment; and specialized software, including central sterile supply department traceability and workflow management systems. Additionally, the company provides turnkey architectural and engineering services for sterile processing department design, cleanroom construction, and facility renovation; equipment maintenance, calibration, validation, and repair services; and outsourced hospital sterilization and medical waste management operations. The company serves public and private hospitals, specialized medical clinics, dental practices, veterinary hospitals, laboratories, and pharmaceutical manufacturers across Thailand and Southeast Asia. Founded in 1970 and headquartered in Samut Prakan, Thailand, the company was formerly known as Namwiwat Medical Corporation Co., Ltd. before converting to a public company and listing its shares on the Stock Exchange of Thailand under the ticker NAM. In recent developments, the company completed its initial public offering on the Stock Exchange of Thailand to finance production facility expansions and international distribution capabilities; established a strategic partnership with Innobic (Asia) Company Limited, the life science subsidiary of PTT Public Company Limited, to accelerate medical device innovation and regional commercialization; expanded its product portfolio with next-generation automated medical waste treatment technologies; and broadened its distribution network across Southeast Asian markets.